High‑dose intravenous methylprednisolone therapy in patients with Graves’ orbitopathy is associated with the increased activity of factor VIII

Miśkiewicz P, Milczarek‑Banach J, Rutkowska‑Hinc B, Kondracka A, Bednarczuk T.
Journal of Endocrinological Investigation.
https://doi.org/10.1007/s40618-018-0907
Ver comentario
Comentado por Dra. Pamela Invernizzi B. y Dra. Vjerocka Inostroza S. Residentes Endocrinología Adulto, Hospital San Juan de Dios.